Dendritic cells vaccine(Dartmouth-Hitchcock Medical Center)(Dendritic cells vaccine(Dartmouth-Hitchcock Medical Center))

概要

基本信息

药物类型

治疗性疫苗、树突状细胞疫苗

别名-

靶点-

作用机制

免疫刺激剂

治疗领域

肿瘤神经系统疾病其他疾病

在研适应症-

非在研适应症

多形性胶质母细胞瘤

原研机构

Dartmouth-Hitchcock Medical Center

在研机构-

非在研机构

Dartmouth-Hitchcock Medical Center

最高研发阶段无进展临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

3

项与 Dendritic cells vaccine(Dartmouth-Hitchcock Medical Center) 相关的临床试验

KCT0000986 / Recruiting临床2期IIT

A prospective, randomized multicenter, open-label, safety and preliminary efficacy study of Immunotherapy in patients with unresectable hepatocellular carcinoma (HCC) treated by transarterial chemoembolization (TACE)

开始日期2013-12-09

申办/合作机构

Kyungpook National University Hospital

NCT01171729 / Completed临床1/2期IIT

A Phase I/IIa Study of Autologous Cell-based Vaccine Therapy With CreaVax-PC in Hormone-Refractory Metastatic Prostate Cancer Patients With PSA Relapse to Evaluate the Safety and Efficacy

This is an open label, Phase I/IIa trial of immunotherapy with CreaVax-PC as treatment in men with hormone-Refractory Metastatic Prostate Cancer.

开始日期2006-07-01

申办/合作机构

Samsung Medical Center

[+1]

NCT00323115 / Completed临床2期IIT

A Phase II Feasibility Study of Adjuvant Intra-Nodal Autologous Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme

Adult patients who have surgical resection of newly diagnosed glioblastoma multiforme will be treated with radiotherapy/chemotherapy followed by dendritic cell vaccine. Chemotherapy will be administered after three vaccinations for one year or until progression of disease.

开始日期2006-05-01

申办/合作机构